| Product Code: ETC7657043 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Next Generation Immunology Drugs Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Next Generation Immunology Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Next Generation Immunology Drugs Market - Industry Life Cycle |
3.4 Israel Next Generation Immunology Drugs Market - Porter's Five Forces |
3.5 Israel Next Generation Immunology Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Next Generation Immunology Drugs Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
4 Israel Next Generation Immunology Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in Israel |
4.2.3 Favorable government initiatives supporting immunology research and development |
4.3 Market Restraints |
4.3.1 Stringent regulatory hurdles in drug approval process |
4.3.2 High costs associated with development and commercialization of next generation immunology drugs |
5 Israel Next Generation Immunology Drugs Market Trends |
6 Israel Next Generation Immunology Drugs Market, By Types |
6.1 Israel Next Generation Immunology Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Next Generation Immunology Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Israel Next Generation Immunology Drugs Market Revenues & Volume, By Small Molecules, 2021- 2031F |
6.1.4 Israel Next Generation Immunology Drugs Market Revenues & Volume, By Antibodies, 2021- 2031F |
6.1.5 Israel Next Generation Immunology Drugs Market Revenues & Volume, By Cell Based Therapies, 2021- 2031F |
6.1.6 Israel Next Generation Immunology Drugs Market Revenues & Volume, By Other Drug Classes, 2021- 2031F |
6.2 Israel Next Generation Immunology Drugs Market, By Therapeutic Area |
6.2.1 Overview and Analysis |
6.2.2 Israel Next Generation Immunology Drugs Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.3 Israel Next Generation Immunology Drugs Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.2.4 Israel Next Generation Immunology Drugs Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.5 Israel Next Generation Immunology Drugs Market Revenues & Volume, By Inflammatory Diseases, 2021- 2031F |
6.2.6 Israel Next Generation Immunology Drugs Market Revenues & Volume, By Other Therapeutic Areas, 2021- 2031F |
7 Israel Next Generation Immunology Drugs Market Import-Export Trade Statistics |
7.1 Israel Next Generation Immunology Drugs Market Export to Major Countries |
7.2 Israel Next Generation Immunology Drugs Market Imports from Major Countries |
8 Israel Next Generation Immunology Drugs Market Key Performance Indicators |
8.1 Number of clinical trials for next generation immunology drugs conducted in Israel |
8.2 Percentage of healthcare professionals adopting new immunology treatment protocols |
8.3 Rate of adoption of immunology drugs with novel mechanisms of action in the Israeli market |
9 Israel Next Generation Immunology Drugs Market - Opportunity Assessment |
9.1 Israel Next Generation Immunology Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Next Generation Immunology Drugs Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
10 Israel Next Generation Immunology Drugs Market - Competitive Landscape |
10.1 Israel Next Generation Immunology Drugs Market Revenue Share, By Companies, 2024 |
10.2 Israel Next Generation Immunology Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here